Other congenital malformations of digestive system

Q17_OTHER_CONGEN_MALFO_DIGES_SYSTEM2

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q45 Cause of death: ICD-10 — Q45 2 out of 7 registries used, show all original rules.	88
4. Check minimum number of events None	88
5. Include endpoints None	88
6. Filter based on genotype QC (FinnGen only)	85

Control definitions (FinnGen only)

Control exclude: Q17_OTHER_CONGEN_MALFO_DIGES_SYSTEM1

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Q3[8-9]|Q4[0-5]
Name in latin: Aliae malformationes congenitae systematis digestorii

NAME	Q17_OTHER_CONGEN_MALFO_DIGES_SYSTEM2
CONTROL_EXCLUDE	Q17_OTHER_CONGEN_MALFO_DIGES_SYSTEM1
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q45
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q45
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other congenital malformations of digestive system based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	600	350	249
Only index persons	515	309	206
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	37.88	37.47	38.37
Only index persons	42.13	40.50	44.57

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	85	47	38
Unadjusted period prevalence (%)	0.02	0.02	0.02
Median age at first event (years)	48.54	49.33	47.57

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
88: Matched controls
879

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Q45.38

ICD-10 Finland

Other congenital malformations of pancreas and pancreatic duct

+∞

32.3

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

7.7

20.8

151

Q45.8

ICD-10 Finland

Other specified congenital malformations of digestive system

+∞

18.4

Q45.30

ICD-10 Finland

Ectopic pancreas

+∞

12.8

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

31.0

8.7

K86.1

ICD-10 Finland

Other chronic pancreatitis

99.0

8.6

Q45.1

ICD-10 Finland

Annular pancreas

+∞

8.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.7

8.1

Q45.0

ICD-10 Finland

Agenesis, aplasia and hypoplasia of pancreas

+∞

7.4

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

+∞

7.4

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

13.6

7.3

A02BC01

ATC

omeprazole; systemic

3.4

6.9

136

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

18.5

6.9

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

43.5

6.9

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.2

6.6

219

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.3

6.4

K85

ICD-10 Finland

Acute pancreatitis

28.9

6.3

Q45.9

ICD-10 Finland

Congenital malformation of digestive system, unspecified

+∞

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3018095) Leukocytes [#/volume] in Urine

258

3.02

6.10

3.8

3.5

77.91

31.61

e6/l

0.44

190

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

338

3.09

5.97

7.6

8.4

1.21

1.22

mmol/l

0.13

296

(3014576) Chloride [Moles/volume] in Serum or Plasma

3.33

5.37

16.2

7.5

104.83

103.62

mmol/l

0.69

(3025941) Bacteria identified in Stool by Culture

4.12

5.32

1.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

264

2.80

5.31

3.4

3.0

—

(40768797) Stomach Pathology biopsy report

3.29

5.27

1.6

1.2

—

(3042936) Bacteria identified in Isolate by Culture

3.20

5.19

1.8

2.7

—

(3048689) Calprotectin [Mass/mass] in Stool

3.14

4.77

2.0

2.2

97.99

143.34

ug/g

0.54

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

15.01

4.65

3.9

1.6

19.57

32.00

umol/l

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

4.41

4.46

1.2

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

206

2.48

4.08

3.1

2.8

0.34

0.44

e6/l

0.24

156

(36304419) Bacteria [Presence] in Urine

205

2.39

3.73

3.4

2.7

—

(3002582) Erythrocytes [#/volume] in Urine

233

2.31

3.57

3.3

2.8

12.28

30.36

e6/l

0.62

182

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

120

2.51

3.40

2.8

0.59

0.67

e6/l

0.13

(3044889) 12 lead EKG panel

482

2.47

3.38

3.8

3.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2.90

3.36

8.6

2.7

41.88

27.07

u/l

0.57

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

109

2.50

3.20

3.0

2.9

2.27

2.22

e6/l

0.01

(3011397) Hemoglobin [Presence] in Urine by Test strip

169

2.28

3.16

3.2

3.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.96

3.15

1.5

1.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

493

2.35

3.03

5.9

4.0

—

(40758558) Short blood count panel - Blood

182

2.19

2.92

7.2

7.8

—

(3023368) Bacteria identified in Blood by Culture

191

2.16

2.88

7.4

4.3

—

(3026008) Bacteria identified in Urine by Culture

215

2.04

2.57

5.1

3.2

—

(3000991) Gas panel - Venous blood

2.62

2.55

9.9

9.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

4.37

2.41

1.1

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

263

1.95

2.39

2.0

1.8

82.06

98.34

pmol/l

1.32

130

(3034770) Mitochondria Ab [Titer] in Serum

4.12

2.30

1.6

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

322

1.89

2.25

3.8

2.7

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

4.51

2.19

1.7

2.0

7.75

3.38

u/ml

—

(3026782) Osmolality of Urine

152

2.01

2.14

2.4

605.33

538.86

mosm/kgh2o

0.33

130

(40760892) CBC W Ordered Manual Differential panel - Blood

331

1.81

1.99

9.6

7.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

148

1.96

1.97

5.0

2.4

—

(3035350) Ketones [Presence] in Urine by Test strip

360

1.81

1.97

4.1

3.7

0.00

estimate

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

4.74

1.96

1.4

1.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

3.36

1.92

2.4

4.7

274.43

188.73

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3.03

1.91

1.9

2.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

298

1.78

1.87

14.8

11.5

1.12

1.22

inr

0.51

(3044640) Blood type and Crossmatch panel - Blood

218

1.82

1.86

4.5

2.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

3.21

1.84

1.7

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

367

1.75

1.79

4.1

3.7

0.00

estimate

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

3.49

1.77

1.2

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.83

1.77

5.3

27.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.07

1.75

1.6

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

122

1.94

1.74

1.7

1.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

4.00

1.73

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

4.00

1.73

1.2

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

361

1.72

1.70

5.9

5.1

0.00

estimate

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

147

1.87

1.70

1.6

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

172

1.82

1.69

1.1

1.3

2.63

2.24

g/l

0.49

102

(36660697) Celiac disease serology panel - Serum

2.25

1.69

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

668

2.21

1.68

20.4

11.8

91.07

84.79

ml/min/173m2

1.18

533

(1761868) Lipid panel - Serum or Plasma

265

0.51

1.59

3.3

2.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.97

1.49

1.3

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.95

1.44

1.3

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2.27

1.38

1.7

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2.88

1.30

1.0

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2.88

1.30

1.0

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

2.72

1.23

1.0

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.06

1.07

15.2

9.6

26.22

25.50

mmol/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.76

1.05

1.5

—

(3021589) Normoblasts [#/volume] in Blood

335

1.48

1.00

12.4

8.2

0.00

e9/l

-0.00

273

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

263

1.47

0.93

3.0

3.4

30.26

32.32

ng/l

0.05

176

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.87

0.80

1.0

1.1

—

(40768793) Breast Pathology biopsy report

0.00

0.80

0.0

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.77

0.78

1.6

1.5

—

(3003338) MCHC [Mass/volume]

655

1.54

0.78

32.2

17.2

332.21

333.42

g/l

0.66

655

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.24

0.77

1.2

1.0

—

(3022145) Colonoscopy Study observation

1.64

0.77

1.1

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1.71

0.76

5.0

4.1

69.11

71.52

ng/l

—

(3029937) Albumin [Presence] in Urine by Test strip

199

1.43

0.74

4.5

3.8

0.00

estimate

—

(3009508) Creatinine [Moles/volume] in Urine

200

1.42

0.72

3.6

3.0

8.10

7.84

mmol/l

0.09

178

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

173

1.44

0.71

2.4

2.0

2.72

0.98

mg/l

0.65

139

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

121

1.50

0.68

1.3

55.48

24.88

iu/ml

—

(3020891) Body temperature

1.76

0.64

5.2

6.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

1.66

0.64

3.4

4.3

4.22

4.84

kpa

—

(3000494) Fungus identified in Specimen by Culture

1.58

0.63

1.5

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.59

0.61

3.6

3.5

1.24

1.22

mmol/l

—

(3014051) Protein [Presence] in Urine by Test strip

0.00

0.61

0.0

1.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1.58

0.59

4.7

4.3

5.83

5.76

kpa

0.09

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

117

1.45

0.57

1.4

1.3

3.48

6.93

u/ml

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

293

1.32

0.57

4.3

3.6

—

(3012544) pH of Venous blood

1.55

0.56

4.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.47

0.54

1.9

3.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.58

0.54

1.3

2.2

—

(1002224) Polysomnography panel

1.53

0.52

1.3

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

147

1.37

0.50

4.2

3.6

23.26

21.33

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.50

0.48

1.4

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.46

0.47

1.6

2.8

4.46

4.58

pmol/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.43

0.46

2.1

2.2

—

(3002256) Pathology report gross observation

1.44

0.45

1.6

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.6

—

173.00

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.41

0.0

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

208

1.28

0.41

4.1

3.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.41

0.0

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.4

—

(3022313) Gas panel - Capillary blood

1.50

0.41

7.4

5.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

523

1.25

0.40

3.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.40

0.40

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

117

1.34

0.38

1.3

1.5

—

(3012516) Albumin [Mass/volume] in Urine

182

1.28

0.38

3.5

3.2

7.59

58.85

mg/l

2.34

127

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.49

0.37

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

109

1.34

0.36

2.6

2.1

12.87

12.93

umol/l

0.01

(3020682) Albumin/Creatinine [Ratio] in Urine

194

1.25

0.34

4.6

3.7

1.79

8.05

mg/mmol

2.06

131

(3019060) Gas panel - Arterial blood

1.32

0.34

6.8

14.8

—

(40761535) Cells panel - Urine sediment

1.29

0.29

3.3

3.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

104

1.29

0.28

2.2

2.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.20

0.25

1.3

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

106

1.26

0.24

3.6

2.6

0.81

0.69

ug/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.37

0.24

1.0

1.9

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.30

0.23

3.0

3.3

0.84

0.76

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.26

0.23

3.0

3.3

0.90

1.41

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.23

0.22

6.0

4.1

24.60

24.07

mmol/l

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.21

0.0

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.7

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

0.00

0.21

0.0

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

0.00

0.21

0.0

1.8

—

688.00

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.21

0.0

1.6

—

(3011412) CD3 cells [#/volume] in Blood

0.00

0.21

0.0

1.8

—

1.52

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.21

0.0

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.27

0.21

1.3

2.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.24

0.20

1.2

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.20

0.0

1.4

—

(40768804) Tissue Pathology biopsy report

282

1.15

0.20

2.0

—

(40761511) CBC panel - Blood by Automated count

780

1.27

0.14

21.1

11.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

114

0.86

0.10

1.1

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

155

1.12

0.09

1.6

1.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1.07

0.09

8.4

4.9

-0.24

1.04

mmol/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.10

0.08

1.7

1.9

—

(3013512) EKG study

188

1.08

0.06

3.7

3.4

—

(3003694) ABO and Rh group [Type] in Blood

208

1.08

0.05

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

0.00

0.0

3.0

—

0.16

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.0

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

0.0

8.4

—

0.56

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.0

1.0

—

(3051651) Icteric interference index of Serum or Plasma

0.00

0.0

1.6

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

0.0

1.4

—

89.11

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.0

7.2

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.0

5.8

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

46.40

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.0

1.6

—

(3034426) Prothrombin time (PT)

0.00

0.0

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

-0.00

0.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.99

-0.00

10.4

7.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(40761536) Microorganisms panel - Urine sediment

0.90

-0.00

11.0

3.2

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(4035726) Immunohistochemistry procedure

0.96

-0.00

1.3

1.5

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

2.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

-0.00

0.0

2.0

—

(3000492) Spirometry study

0.88

-0.00

1.6

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

2.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

136.92

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

-0.00

0.0

1.0

—

(21494755) Public health laboratory ask at order entry panel

1.01

-0.00

1.4

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

-0.00

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3011648) Oxygen content in Venous blood

0.00

-0.00

0.0

1.0

—

9.63

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_OTHER_CONGEN_MALFO_DIGES_SYSTEM2 and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have Q17_OTHER_CONGEN_MALFO_DIGES_SYSTEM2.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: Q17_OTHER_CONGEN_MALFO_DIGES_SYSTEM2 – Other congenital malformations of digestive system

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other congenital malformations of digestive system

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints